Clinical Trials Sponsored by Dartmouth-Hitchcock Medical Center

Total 559 results

Dartmouth-Hitchcock Medical Center
Celgene Corporation

Terminated

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

Neuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

United States
Dartmouth-Hitchcock Medical Center
Maastricht University

Terminated

Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort

Crohn's Disease

United States
Dartmouth-Hitchcock Medical Center
Genentech, Inc.

Completed

Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

United States
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Withdrawn

Apremilast Therapy for Acute Gouty Arthritis

Acute Gout

United States
Dartmouth-Hitchcock Medical Center
Novartis Pharmaceuticals

Terminated

Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung

Cystic Fibrosis

United States
ChiRhoClin, Inc.
Dartmouth-Hitchcock Medical Center

Completed

Secretin Infusion for Pain Due to Chronic Pancreatitis

Chronic Pancreatitis

United States
Dartmouth-Hitchcock Medical Center
Creare, Inc.

Completed

Evaluating Instrumentation for Dental Devices Used in Treating Sleep Apnea

Obstructive Sleep Apnea

United States
Dartmouth-Hitchcock Medical Center
CTI BioPharma

Completed

Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)

Advanced Non-small Cell Lung Cancer

United States
Mayo Clinic
Dartmouth-Hitchcock Medical Center

Completed

A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters

Blood Pressure

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI); Dartmouth College

Completed

Screen to Save 2: Rural Cancer Screening Educational Intervention

Cancer | Colorectal Cancer | Lung Cancer

United States
Dartmouth-Hitchcock Medical Center
Harbor Medical Inc.

Completed

Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections (Sprixx-ICU)

Nosocomial Infection

United States
Dartmouth-Hitchcock Medical Center
Harbor Medical Inc.

Completed

Potential Nosocomial Infection Prevention Via Modification of Anesthesia Intraoperative Aseptic Practice

Nosocomial Infections

United States
Ryan J. Halter
Dartmouth College

Not yet recruiting

RetracTOR/ Retractor for Image Guided Trans-Oral Surgery

Oral Cavity Disease

United States
Ryan J. Halter
Dartmouth College

Recruiting

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment (RARP EI)

Prostate Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Recruiting

A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Aspirin/Folate Prevention of Large Bowel Polyps

Colorectal Cancer | Polyps | Adenomas

United States, Canada
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Randomized Controlled Trial (RCT) of a Motivational Decision Support System (RCTEDSS)

Schizophrenia

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness

Psychotic Disorders | Tobacco Smoking | Mental Illness

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Leukemia

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

Lung Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Metastatic Renal Cell Carcinoma

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women

Cervical Cancer | Breast Cancer | Colorectal Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Health Education in Improving the Understanding of Medical Information

Unspecified Adult Solid Tumor, Protocol Specific
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Sarcoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Melanoma (Skin) | Carcinoma of Unknown Primary

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Cachexia

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Not yet recruiting

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2) (iPath Pilot)

Depression | Cancer
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Developing an Experimental Framework to Evaluate Oncologist Emotion Regulation

Communication

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Screen to Save: A Colorectal Cancer Educational Intervention (S2S)

Colorectal Cancer

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

Kidney Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

Brain Tumors | Central Nervous System Tumors | Leptomeningeal Metastases

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Brain and Central Nervous System Tumors

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Recruiting

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

An Intraoperative Guidance Platform for Radio Frequency Ablation

Hepatocellular Carcinoma

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Variation in Cancer Centers' End-of-Life Quality

Advanced Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Completed

Reducing Disability in Older Adult Cancer Survivors

Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Vitamin D/Calcium Polyp Prevention Study

Colorectal Cancer | Polyps | Adenomas

United States, Puerto Rico
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Terminated

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Participation Restrictions in Breast Cancer Survivors

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Nathaniel M. Robbins

Withdrawn

The Role of the Noradrenergic System in the Nonmotor Symptoms of Parkinson's Disease (NAinPD)

Parkinson Disease

United States

Clinical Trials Sponsored by Dartmouth-Hitchcock Medical Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations